经验和挑战与新的欧洲临床试验法规
Thale D J H Patrick-Brown1, Josephine Bourner2, Sabrina Kali3
1Clinic for Surgery, Inflammatory Medicine and Transplantation (KIT Research), Oslo University Hospital, Oslo, Norway. d.j.patrick-brown@medisin.uio.no.
Trials
|January 3, 2024
概括
欧洲新的临床试验信息系统 (CTIS) 没有降低临床试验的行政负担,尽管有承诺. 延误和技术问题阻碍了研究,特别是疫情防控.
科学领域:
- 临床研究法规临床研究法规
- 欧洲药品管理局 (EMA) 是欧洲药品管理局.
- 传染病研究传染病研究.
背景情况:
- 欧洲药品署 (EMA) 根据临床试验法规 (CTR EU 536/2014) 于2022年1月31日实施临床试验信息系统 (CTIS).
- CTIS的目的是简化欧洲范围内的临床试验注册流程.
- 这项研究利用了三项欧洲跨国研究的经验,这些研究重点关注易爆发的传染病.
研究的目的:
- 评估新的CTIS提交程序的优缺点.
- 评估CTIS对跨国临床研究的实际影响.
- 确定欧洲临床试验监管框架的挑战和需要改进的领域.
主要方法:
- 对三项多国欧洲研究的监管和伦理审批的时间分析.
- 评估申请档案的大小和信息请求 (RFI) 的数量.
- 使用CTIS对欧盟和非欧盟监管环境中的研究经验进行定性评估.
主要成果:
- 虽然审批时间有所改善,但审批时间仍然很慢,特别是在与疫情相关的研究中.
- 发现了相互冲突的申请要求,增加的文件负担和提交障碍.
- 在CTIS平台中遇到重大技术障碍和削弱性问题.
结论:
- CTIS尚未实现其减少临床试验行政负担的目标.
- 迫切需要改进,以解决系统的局限性和延误.
- 当前系统的低效性给跨国研究带来了挑战,特别是在疫情防控和应对方面,这引发了伦理方面的担忧.
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
129
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129
Drug Control Governance: Regulatory Bodies and Their Impact
160
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
160


